Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideTMOThermo Fisher Scientific
FinDog View：Neutral
| Metric | RMD | TMO |
|---|
| Close | 229.94 | 697.00 |
| Market Cap | $32.6B | $258B |
| 1M | +4.00% | +3.25% |
| P/E (TTM) | 21.5 | 36.4 |
| Forward P/E | 18.0 | 24.6 |
| P/E 5-Yr Percentile | 11 | 78 |
| P/S | 5.8 | 5.4 |
| P/B | 5.0 | 4.7 |
| Dividend Yield | 1.25% | 0.29% |
| Latest Quarter Revenue | $1.4B | $12.1B |
| Revenue YoY | +5.9% | +9.1% |
| Gross Margin | 61.5% | — |
| Latest Quarter EPS | 2.92 | 4.64 |
| Avg Post-Earnings Move | ±2.6% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 5.65% | 1.82% |
| 90-Day Net Insider Buying | −$5.4M | −$40.3M |
RMD · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
